Skip to main content
Xiaodong Yang, MD, Anesthesiology, Los Angeles, CA

XiaodongYangMDMS

Anesthesiology Los Angeles, CA

Cardiothoracic Anesthesiology, Critical Care Medicine

Mount Sinai/ Cedars Sinai

Dr. Yang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Yang's full profile

Already have an account?

Education & Training

  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiFellowship, Adult Cardiothoracic Anesthesiology, 2010 - 2011
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiFellowship, Critical Care Medicine, 2009 - 2010
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Anesthesiology, 2005 - 2009
  • Flushing Hospital Medical Center
    Flushing Hospital Medical CenterResidency, Internal Medicine, 2002 - 2005
  • West China University of Medical Sciences
    West China University of Medical SciencesClass of 1994

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2011 - 2025
  • NY State Medical License
    NY State Medical License 2010 - 2025
  • American Board of Anesthesiology Anesthesiology

Publications & Presentations

PubMed

Press Mentions

  • Apexigen Reports Third Quarter 2022 Financial Results and Provides Business Update
    Apexigen Reports Third Quarter 2022 Financial Results and Provides Business UpdateNovember 15th, 2022
  • Apexigen Announces Nature Medicine Publication and ASCO Presentation on the Phase 2 PRINCE Trial Showcasing Distinct Biosignatures in Metastatic Pancreatic Cancer Patients Treated with Sotigalimab and/or Nivolumab in Combination with Chemotherapy
    Apexigen Announces Nature Medicine Publication and ASCO Presentation on the Phase 2 PRINCE Trial Showcasing Distinct Biosignatures in Metastatic Pancreatic Cancer Patients Treated with Sotigalimab and/or Nivolumab in Combination with ChemotherapyJune 6th, 2022
  • Apexigen to Host Key Opinion Leader Webinar on Sotigalimab in Post-Anti-PD-(L)1 Melanoma
    Apexigen to Host Key Opinion Leader Webinar on Sotigalimab in Post-Anti-PD-(L)1 MelanomaNovember 9th, 2021
  • Join now to see all